This phase 2 trial tested an experimental implant called ATX101 that slowly releases the numbing drug bupivacaine into the knee after total knee replacement surgery. The study involved 226 adults and compared ATX101 to a saline placebo and standard bupivacaine injections. The goa…
Phase: PHASE2 • Sponsor: Allay Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC